Cover Image

Anti-multiple myeloma drug-associated taste dysfunction: An analysis of the FAERS database

Saved in:

Bibliographic Details
Main Authors:	Ayano Inoba (Author), Kaori Kadoyama (Author), Keiko Minami (Author), Akiko Tamon (Author), Masahiro Tsuda (Author), Toshiyuki Sakaeda (Author), Yasushi Okuno (Author)
Format:	Book
Published:	Elsevier, 2016-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characterization of Antineoplastic Agents Inducing Taste and Smell Disorders Using the FAERS Database
by: Risa Hamazaki, et al.
Published: (2024)

Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
by: Yuan Peng, et al.
Published: (2024)

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022
by: Marwan A. Alrasheed, et al.
Published: (2024)

PlantMolecularTasteDB: A Database of Taste Active Phytochemicals
by: Teodora-Cristiana Gradinaru, et al.
Published: (2022)

Analysis of Factors Associated with Hiccups Using the FAERS Database
by: Ryuichiro Hosoya, et al.
Published: (2021)

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
by: Madigan D, et al.
Published: (2018)

Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database
by: Wangyu Ye, et al.
Published: (2024)

Drug-induced hearing disorders: a disproportionality analysis of the FAERS database
by: Baojian Li, et al.
Published: (2024)

Mining and evaluation of adverse event signals for capmatinib based on the FAERS database
by: Xinnan Chen, et al.
Published: (2024)

Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database
by: Risako Hirai, et al.
Published: (2023)

Signal detection and analysis of adverse events associated with Genvoya® based the FAERS database
by: Chengliang Wang, et al.
Published: (2024)

Neratinib safety evaluation: real-world adverse event analysis from the FAERS database
by: Yunhe Fan, et al.
Published: (2024)

Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
by: Shihao Chen, et al.
Published: (2024)

Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database
by: Zhao Li, et al.
Published: (2024)

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database
by: Chang Ge, et al.
Published: (2024)

Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database
by: Heenam Seo, et al.
Published: (2023)

Pathogenesis and treatment of multiple myeloma bone disease
by: Masahiro Hiasa, et al.
Published: (2021)

Sleep disorders as independent predictors of taste dysfunction risk
by: Rongcai Huang, et al.
Published: (2024)

Bullous pyoderma gangrenosum in patients with ulcerative colitis and multiple myeloma
by: Hideo Takenoshita, et al.
Published: (2014)

The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
by: Xiaogan Wang, et al.
Published: (2024)

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
by: Jianxing Zhou, et al.
Published: (2022)

Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database
by: Ningsheng Tian, et al.
Published: (2024)

Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
by: Dan Li, et al.
Published: (2024)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
by: Hui Zhao, et al.
Published: (2023)

Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database
by: Qing Wan, et al.
Published: (2022)

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004-2023)
by: Lin Chen, et al.
Published: (2024)

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases
by: Shupeng Zou, et al.
Published: (2024)

Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database
by: Yusen Zhou, et al.
Published: (2024)

Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database
by: Wensheng Liu, et al.
Published: (2023)

Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
by: Yasuo Okada, et al.
Published: (2021)

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
by: Fan Zou, et al.
Published: (2023)

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
by: Liyuan Liu
Published: (2024)

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
by: Qian Liu, et al.
Published: (2024)

Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
by: Xiaodan Zhou, et al.
Published: (2024)

Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database
by: Feng Liu, et al.
Published: (2024)

Evaluation of taste score and fungiform papillae quantification using digital image analysis in COVID-19 patients with smell and taste dysfunction
by: Vidya Chikkarahalli Srikantaiah, et al.
Published: (2024)

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
by: Shi-Nan Wu, et al.
Published: (2024)

Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database
by: PingPing Long, et al.
Published: (2024)

Safety assessment of neurokinin-1 receptor antagonist: real-world adverse event analysis from the FAERS database
by: Chuanli Yang, et al.
Published: (2024)

Signal mining and analysis of trifluridine/tipiracil adverse events based on real-world data from the FAERS database
by: Yongli Hu, et al.
Published: (2024)